settlements

Testimonials

Natasha F., Ga.

I received a call within 5 minutes of submitting my request! I was amazed at the prompt response!
Ann M., Penn.

The service was great, prompt response. Thank you!
Joseph E., Al.

I received a call within 5 minutes of submitting my request! I was amazed at the prompt response! The service was great, prompt response. Thank you! I am telling others how much easier it is than to go through a phone book and look at ads.
Debra S., Ca.

I am telling others how much easier it is than to go through a phone book and look at ads.
Bob M., Ky.

I think your service is great! Without your help I would not have been able to find an attorney knowledgeable for my needs.
Ann M., Penn.

The service was great, prompt response. Thank you!
Aisha B., Md

The attorney that responded was very professional, resourceful, helpful and courteous to me in regards to my situation. Thank you.

The big pharmacy giants’ have been known to bend a few rules. Thanks to the vigilance of the consumer and with help from experienced lawyers these companies are getting caught. Novartis® for example has recently settled with the US attorney’s office for 422.5 Million Dollars.

Looking back at past cases filed with the Department of Justice and fines imposed by the government for improper marketing and other infractions. These fines range from a light verbal slap on the wrist all the way to multi-billion dollar settlements.

Just in the past 22 months alone eleven companies have paid over $6 billion to the government. One of the largest offenders, Zyprexa® by Eli Lilly has made three court appearances with over 1.4 billion dollars in fines. Those settlements alone pale in comparison to Pfizer’s giant 2.3 Billion charge for mis-marketing on a wide array of pharma drugs, including Lyica®, Bextra®, Geodon® and Zyvox®.

Novartis
With: U.S. Attorney's office for the Eastern District of Pennsylvania
When: Sept. 30, 2010
Scoop: Novartis agreed to a $422.5 million settlement with the Eastern District of Pennsylvania for its off-label promotion of Trileptal and other allegations against Diovan, Exforge, Sandostatin, Tekturna and Zelnorm.

Forest Labs
With: Dept. of Justice
When: Sept. 15, 2010
Scoop: After marketing Levothroid, an unapproved thyroid drug, Forest Labs received its penalty, to the tune of $313 million. The settlement also covered Forest's off-label use of Celexa for children's use.

Allergan
With: Dept. of Justice
When: Sept. 1, 2010
Scoop: Allergan's $600 million DoJ settlement was broken into two parts: $375 million in fines and $225 milion in civil penalties, all of which stemmed from its off-label use of Botox for headaches, pain management and cerebral palsy.

Elan
With: U.S. Attorney's Office in Massachusetts
When: July 15, 2010
Scoop: The Irish drugmaker received its $203.5 million fine for its marketing tactics of Zonegran, an epilepsy drug. Also, the company's U.S. branch pled guilty to a misdemeanor and the company will enter into a corporate integrity agreement with the HHS Inspector General.

First Name:

Last Name:

Address:

Zipcode:

City:

State:

Primary Phone:

Email:

Tell us about your case.

By leaving this box checked, I agree that submission does not establish an attorney client relationship and may be reviewed by one or more law firms. I agree to receive future announcements from our firm and partners.

Please fix these first